We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMGWP
RNS Number : 8143O
GW Pharmaceuticals PLC
13 March 2009
13 March 2009
GW Pharmaceuticals plc
("GW" or "the Company")
SCHEDULE 11
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Mr James Noble, a non-executive Director, has notified the Company that on 12th
March a family member purchased 42,500 ordinary shares of 0.1 pence each in the
Company, at an average price of 58.6p per share.
Following this transaction Mr James Noble has a beneficial interest in 72,500
ordinary shares, amounting to 0.06% of the voting rights of the Company.
Enquiries:
+---------------------------------------------------+-------------------------------+
| GW Pharmaceuticals plc | 01980 557000 |
| | |
| Adam George, Company Secretary | |
+---------------------------------------------------+-------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSGCGDXXXBGGCX
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
